Controlled Release Drug Delivery Market

Controlled Release Drug Delivery Market - Overview

Controlled release drug delivery is a type of dosage in which medication or drug is delivered in a predetermined manner. It is a system that delivers medication or drug continuously in reproducible and predictable kinetics for a predetermined time period during gastrointestinal transit. It slowly releases the drug until it reaches the desired location in the GI tract. Controlled release drug delivery systems use drug-encapsulating devices to release medication or drug at a controlled rate over a long period of time, between days and months. Controlled release drug delivery systems have numerous advantages, including improved drug stability, lower dose requirements, improved drug safety, fewer side effects, higher bioavailability, efficacy, and increased patient compliance. The increasing demand from pharmaceutical sector is projected to augment the sales growth of the global controlled release drug delivery market during the forecast period set between 2021 and 2031.

The controlled release drug delivery market is categorized on the basis of technology, release mechanism, application, and regions. In terms of technology, the market is grouped into targeted delivery, transdermal, implants, micro encapsulation, coacervation, wurster technique, and others such as liposomes, microelectromechanical technology, and others. Based on release mechanism, the market is categorized into chemically activates, activation-modulated drug delivery systems, feedback regulated drug delivery systems, micro reservoir partition controlled drug delivery systems, and polymer based systems.

The research report on the controlled release drug delivery industry provides an elaborate overview of the market and factors promoting or demoting its growth. This includes drivers, restraints, challenges, and future growth opportunities. List of the players operating in this market and their efforts to obtain a significant position in the market competition in terms of innovations and new product launches is also discussed in details. It also focuses on the recent developments and innovations that helped the market grow in terms of revenue generation. The impact of the novel COVID19 pandemic is also discussed in the report. For more information on the report, refer to the company website.

Controlled Release Drug Delivery Market - Competitive Landscape

The nature of competition for this market is significantly competitive attributed to the presence of a handful of players. Leading players of the Controlled Release Drug Delivery market are engaging in joint ventures and merger strategies to gain an upper hand in the overall market competition. Others are investing in introduction of innovative products to attract more revenues to the market. The key objective is to ensure a significant position in the market competition and earn handsome revenues for the overall market.

Some of the key players of the global Controlled Release Drug Delivery market include:

• Capsugel
• Aradigm Corporation
• Pfizer Inc.
• Depomed Inc.
• Corium International Inc.
• Johnson and Johnson
• Alkermes Plc.
• Merck and Co. Inc.
• Orbis Biosciences Inc.
• Others

Controlled Release Drug Delivery Market - Growth Drivers

The increasing need to enhance the shelf-life and accomplish controlled drug release of highly volatile and complex molecules such as vitamins, proteins, and antioxidants is expected to promote the growth of the microencapsulation segment. Implantable systems improve efficiency, provide convenience, reduce side effects, and ensure linear drug delivery over a specified time period. With increased usage, these systems are expected to command a significant share of the controlled release drug delivery market in the near future.

Controlled Release Drug Delivery Market - Geographical Insights

Geographically, this market is widespread into the regions of Latin America, Europe, North America, and the Middle East and Africa. These regions are further categorized as per the nations bringing business. North America emerged as the largest revenue generator for the controlled release drug delivery market on account of the increasing rate of patient pool for chronic diseases and diabetes. Besides this, the presence of major players in the developed nations and increasing number of research and development activities are further expected to help this region continue to dominate the market in the near future.